What is Amir Cohen’s SRTA share ownership after these transactions?

He directly owned 121,342 shares after the reported transactions.

Was there a purchase price for the PSU-related share acquisition?

The acquisition price was $0 , reflecting PSU vesting upon performance certification.

Strata Critical Medical CAO now holds 121,342 shares after PSU vest

Q: Who is the reporting person and role for SRTA?

Amir Cohen , the company’s Chief Accounting Officer , is the reporting person.

Q: How many SRTA shares were acquired from PSU vesting?

41,786 shares were acquired on 10/31/2025 upon certification of performance criteria for PSUs.

Q: How many SRTA shares were withheld for taxes and at what price?

20,497 shares were withheld at $5.03 on 11/03/2025 to satisfy tax obligations.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Strata Critical Medical, Inc. reported insider equity activity by its Chief Accounting Officer, Amir Cohen. On 10/31/2025, Cohen acquired 41,786 shares at $0 upon certification of performance criteria tied to previously granted PSUs. On 11/03/2025, 20,497 shares were withheld by the company at $5.03 to cover taxes related to that vesting. Following these transactions, Cohen directly owned 121,342 shares.

Insider Trade Summary

Net Buyer: 21,289 shares

Net Buy 2 txns

Insider Cohen Amir

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Class A common stock, $0.0001 par value per share	20,497	$5.03	$103K
Grant/Award	Class A common stock, $0.0001 par value per share	41,786	$0.00	$0.00

Holdings After Transaction: Class A common stock, $0.0001 par value per share — 121,342 shares (Direct)

Footnotes (2)

F1. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024.
F2. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/05/2025 - 04:52 PM

FAQ

What did SRTA disclose in this Form 4?

The CAO, Amir Cohen, reported PSU-related transactions: acquisition of 41,786 shares at $0 on 10/31/2025 and withholding of 20,497 shares at $5.03 on 11/03/2025 for taxes.

Who is the reporting person and role for SRTA?

Amir Cohen, the company’s Chief Accounting Officer, is the reporting person.

How many SRTA shares were acquired from PSU vesting?

41,786 shares were acquired on 10/31/2025 upon certification of performance criteria for PSUs.

How many SRTA shares were withheld for taxes and at what price?

20,497 shares were withheld at $5.03 on 11/03/2025 to satisfy tax obligations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cohen Amir

(Last)

(First)

(Middle)

C/O STRATA CRITICAL MEDICAL, INC.

31 HUDSON YARDS, 14TH FLOOR

(Street)

NEW YORK

10001

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A common stock, $0.0001 par value per share	10/31/2025		A		41,786⁽¹⁾	A	$0	141,839	D
Class A common stock, $0.0001 par value per share	11/03/2025		F		20,497⁽²⁾	D	$5.03	121,342	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024.

2. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.

Remarks:

	/s/ Melissa M. Tomkiel, Attorney-in-fact for Amir Cohen	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR